How Payer Friction and Patient Drop-Off Undermine Obesity GLP-1 Uptake The GLP-1 market is experiencing unprecedented demand, yet despite its clinical promise for obesity, diabetes, and other conditions, patient behavior and friction throughout the treatment journey continue to erode its commercial potential
One of our friends is actually using them, which gave us some extra confidence
The semaglutide absorbs directly through the sublingual mucosa into the capillary bed beneath the tongue, bypassing the digestive system entirely
Potential side effects can vary by product, so always speak to a health care provider with any questions
Additionally, GLP-1 medications can cause nausea or vomiting in the immediate postoperative period, which your surgical team will monitor closely